GO
Loading...

Cerner Corp

More

  • U.S. stock index futures added to gains after European Central Bank President Mario Draghi said growth risks are on the downside and should be contained by effective policymaker action. Brokerages Canaccord Genuity, Robert W. Baird& Co, Mizuho Securities USA, BMO Capital Markets and ThinkEquity Llc cut their price targets on the stock.

  • U.S. stock index futures added to gains after European Central Bank President Mario Draghi said growth risks are on the downside and should be contained by effective policymaker action. **NUVASIVE INC, Wednesday close $22.62, down 29.3 pct premarket. **INFORMATICA CORP, Wednesday close $33.63, down 19.7 pct premarket.

  • U.S. stock index futures pointed to a higher open on Wall Street on Thursday, with futures for the S&P 500, the Dow Jones and the Nasdaq 100 rising between 0.2 and 0.5 percent. **NUVASIVE INC, Wednesday close $22.62, down 27.4 pct premarket.

  • *Jefferies starts Cerner Corp with hold rating. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

  • Allscripts gains as analysts ponder report of sale Monday, 1 Oct 2012 | 2:32 PM ET

    NEW YORK-- Shares of Allscripts Healthcare Solutions Inc. continued to rise Monday as Wall Street evaluated a report that the electronic health records company may sell itself to a private buyer. THE SPARK: Bloomberg News reported Friday that Allscripts is considering a sale and had engaged Citigroup Inc. as it considered its options.

  • Sizzling Summer Stocks – Top Trades for Q3 Thursday, 28 Jun 2012 | 7:15 PM ET

    Looking for trades that are about to heat up? Summer may be the right season for the following 4 stocks.

  • Top 10 Tech ETFs of the Past Three Years Monday, 14 May 2012 | 3:51 PM ET
    As the JPMorgan Chase trading loss and European debt mess rekindle memories of the financial crisis of 2008-2009, it’s easy to forget how much U.S. stocks have bounced back since then. Until the recent turbulence, the major indices were at notable level. Specifically, the tech sector was at its highest level since the bubble days of a decade ago. And despite all the hand wringing of late, the Nasdaq Composite is still only off some 5 percent from its April peak. Given tech’s market leadership th

    Given tech’s market leadership this year and the emerging comparisons to the crisis of several years ago, we rounded up the 10 best performance tech ETFs over the past three years.

  • Cramer's Investing Edge: Buy on a High?     Friday, 27 Apr 2012 | 7:41 PM ET

    Today's modest market rise was powered by Amazon, Expedia and Cerner. But for those who missed the surge, Mad Money host Jim Cramer, says it might still be a buying opportunity.

  • Here are Today's Winners on the Biotech Index Thursday, 19 Apr 2012 | 2:27 PM ET
    GlaxoSmithKline

    Human Genome Sciences is one of the reasons the NYSE Arca Biotech Index is having its best day since December 2010.

  • Were You Better Off Buying Dell than Apple 23 Years Ago? Wednesday, 18 Apr 2012 | 2:21 PM ET
    Madonna in 1989

    We may still be listening to Madonna today – who topped the charts with “Like a Prayer” in 1989 – but time has not stood still for your money.

  • Cramer makes the call on viewers' favorite stocks.

  • Your First Move For Tuesday April 3rd Monday, 2 Apr 2012 | 6:46 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • 20 Stocks With the Potential to Drop (Q1 2012) Wednesday, 21 Mar 2012 | 4:25 PM ET
    It's the basic question when investing in a stock: is it on the way up or down? The street has developed numerous ways of attempting to predict what will happen, estimating various attributes tied to stock performance in order to determine what the future holds for a company's valuation. After dissecting the data, analysts following a particular stock produce a price target of where they believe the stock is headed. With data from Thomson Reuters, CNBC.com grouped stocks in the S&P 500 with aver

    It's the basic question when investing in a stock: is it on the way up or will it go down? Wall Street has developed numerous ways of attempting to predict what will happen.

  • Jim Cramer: Play This Health Care Tech Name, Not That Thursday, 15 Mar 2012 | 6:42 PM ET

    The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.

  • Cramer's Case to Sell Allscripts     Thursday, 15 Mar 2012 | 6:15 PM ET

    Mad Money's Cramer explains why the best way to play the expansion of electronic medical records is to sell Allscripts and swap into Cerner, the next time the stock gets pulled down with the rest of the market.

  • Is the Tech Rally Fooling You? Friday, 2 Mar 2012 | 5:43 PM ET
    NYSE Trader

    Technology stocks have been gaining momentum in 2012, up eight of the last nine weeks.  However, over the last 12 months, consumer discretionary and health care companies have really powered the rally.

  • Stocks on the Move Now: Caesars Entertainment Soars Wednesday, 8 Feb 2012 | 11:16 AM ET
    By The Numbers | Stocks on the Move Now

    Caesars Entertainment is among several companies showing unusual movement in Wednesday's trading session.

  • How Investors Can Diversify When Markets Move Together Friday, 14 Oct 2011 | 12:46 PM ET

    When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.

  • Throw Back The Big Ones Friday, 20 May 2011 | 2:47 PM ET
    Cost of healthcare

    Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.

  • Cramer: Nasdaq Rebalancing Won't Keep Apple Down Friday, 29 Apr 2011 | 3:48 PM ET

    The "Mad Money" host also talks Cerner, Allscripts and Wabco